{"entity":{"id":"730787b3-c2f1-52c8-9a39-14bc7c0b46f0","name":"Ho Yu Ling","type":"Organization","kind":"company","jurisdiction":"HK","identifier":"icij:icijol-50643","risk":"MED","flags":[]},"identity":{"linked_records":[],"also_known_in":[]},"ownership":{"direct_owners":[],"holdings":[{"role":"director of","share":null,"asset":{"id":"9be4091c-1855-546e-80b9-55d7da76480f","name":"SOUTH ASIA PHARMACEUTICAL (CHINA) LIMITED","type":"Company","kind":"company"}}],"ubo_chain":[]},"risk":{"level":"MED","flags":[],"note":"Risk is a layer-1 signal (offshore-layering / connectivity heuristics) — an investigative lead, not a determination."},"sources":[{"registry":"icij_offshoreleaks","source_url":"https://offshoreleaks.icij.org/nodes/50643"}],"source":"corpus"}